Test Bank for Davis Advantage for Townsend's Psychiatric Mental Health Nursing, 11th Edition by Karyn I. Morgan All Chapters included Latest 2024 ISBN: 9781719648240 Newest Version Pdf

TESTBANK- ui




Davis Advantage for Psychiatric Mental Health Nursing
ui ui ui ui ui ui




ui Karyn I. Morgan
ui ui




11th Edition
ui

, Table of u i u i Contents

Chapter 01. The Concept of Stress Adaptation
ui ui ui ui ui ui


Chapter 02. Mental Health/Mental Illness: Historical and Theoretical
ui ui ui ui ui ui ui


Concepts
ui


Chapter 03. Psychopharmacology
u i u i


Chapter 04. Concepts of Psychobiology
ui ui ui ui ui


Chapter 05. Ethical and Legal Issues in Psychiatric/Mental Health Nursing
ui ui ui ui ui ui ui ui ui


Chapter 06. Cultural and Spiritual Concepts Relevant to Psychiatric/Mental Health
u i u i u i u i u i u i u i u i u i


Nursing Chapter 07. Relationship Development
u i ui u i u i u i


Chapter 08. Therapeutic Communication
ui ui ui


Chapter 09. The Nursing Process in Psychiatric/Mental Health Nursing
ui ui ui ui ui ui ui ui


Chapter 10. Therapeutic Groups
ui u i u i u i


Chapter 11. Intervention With Families
u i u i u i u i


Chapter 12. Milieu Therapy - The Therapeutic Community
ui ui ui ui ui ui ui


Chapter 13. Crisis Intervention
ui u i u i u i


Chapter 14. Assertiveness Training
ui ui ui


u Chapter 15. Promoting Self-Esteem
i ui ui ui


Chapter 16. Anger/Aggression
u i ui ui


M anagement Chapter 17. The Suicidal
ui ui u i u i u i


Client
u i


Chapter 18. Behavior Therapy
u i u i u i


Chapter 19. Cognitive Therapy
ui u i u i u i


Chapter 20. Electroconvulsive
ui ui ui


Therapy Chapter 21. The
ui u i u i u i


Recovery Model Chapter 22.
ui ui u i u i


Neurocognitive Disorders
u i ui


Chapter 23. Substance-Related and Addictive Disorders
u i u i u i u i u i


Chapter 24. Schizophrenia Spectrum and Other Psychotic Disorders
ui ui ui ui ui ui ui


Chapter 25. Depressive Disorders
ui u i u i u i


Chapter 26. Bipolar and Related Disorders
u i u i u i u i u i


Chapter 27. Anxiety, Obsessive-Compulsive, and Related Disorders
ui ui ui ui ui ui


Chapter 28: Trauma and Stressor-Related Disorders
ui u i u i u i u i u i


Chapter 29. Somatic Symptom and Dissociative Disorders
u i u i u i u i u i u i


Chapter 30. Issues Related to Human Sexuality and Gender Dysphoria
ui ui ui ui ui ui ui ui ui


Chapter 31. Eating Disorders
ui u i u i u i


Chapter 32. Personality Disorders
u i u i u i


Chapter 33. Children and Adolescents
ui ui ui ui ui


Chapter 34. The Aging Individual
ui u i u i u i u i


Chapter 35. Survivors of Abuse or Neglect
u i u i u i u i u i u i


Chapter 36. Community Mental Health Nursing
ui ui ui ui ui ui


Chapter 37. The Bereaved Individual
ui u i u i u i u i


Chapter 38. Military Families
ui u i u i

,Chapter 01. Psychopharmacology u i u i




Multiple Choice ui




1. The NURSE manager on the psychiatric unit was explaining to the new staff
ui u i ui ui ui u i ui ui u i u i u i u i


the differences between typical and atypical antipsychotics. The NURSE correctly
ui u i ui u i u i u i u i u i u i u i


states that atypical antipsychotics:
u i u i u i ui




A. Remain in the system longer u i u i ui ui




B. Act more quickly to reduce delusions
ui ui ui ui u i




C. Produce fewer extrapyramidal effects
u i u i u i




D. Are risk free for neuroleptic malignant syndrome (NMS)
u i ui ui ui u i u i u i




CORRECT qANSWER:C ui




Atypical antipsychotics produce less D2blockade; thus movement disorders are less of a
u i u i u i u i u i u i u i u i u i u i u i


problem. No evidence suggests that the medication remains in the system longer nor that it acts more
u i u i ui ui ui ui ui ui ui ui ui ui ui ui ui ui ui


quicklyto reduce delusions. The atypicals are not risk free for NMS.
ui ui ui u i u i u i u i u i u i u i u i




KEY: Cognitive Level: Application | Integrated Processes: Nursing Process: Implementation
ui u i u i u i ui u i ui ui ui u i |
Client Need:
ui u i


Physiological Integrity: Pharmacological and Parenteral Therapies
ui ui ui ui ui




2. The NURSE would assess for neuroleptic malignant syndrome (NMS) if a
ui ui u i ui u i u i ui u i ui u i


patient on haloperidol (Haldol) develops a:
ui ui ui u i u i u i




A. 30 mm Hg decrease in blood pressure reading
u i ui ui u i u i u i u i




B. Respiratory rate of 24 respirations per minute ui u i u i u i u i u i




C. Temperature reading u i u i of 104° u i u i F

D. Pulse rate of 70 beats per minute
u i u i u i u i u i u i




CORRECT qANSWER:C ui




Increased temperature is the cardinal sign of NMS. This BP is not a significant feature of
u i u i u i u i u i u i ui ui u i u i u i ui u i u i u i


NMS. There are no significant findings to support the options related to respirations or
ui ui u i ui u i u i u i u i u i u i u i u i u i u i


pulse rate.
u i u i




KEY: Cognitive Level: Application | Integrated Processes: Nursing Process: Assessment | Client
ui u i ui u i ui u i u i u i ui u i ui


Need:
u i


Physiological Integrity: Pharmacological and Parenteral Therapies
ui ui ui ui ui




3. A patient taking fluphenazine (Prolixin) complains of dry mouth and blurred vision.
u i ui u i u i ui u i ui ui u i ui u i


What would the NURSE assess as the likely cause of these symptoms?
u i u i u i ui u i u i u i u i u i u i u i u i




A. Decreased dopamine at receptor sites ui ui ui u i




B. Blockade of histamine ui ui




C. Cholinergic blockade u i




D. Adrenergic blocking u i




CORRECT qANSWER:C ui




Fluphenazine administration produces blockade of cholinergic receptors giving rise to
u i u i ui ui ui u i u i u i ui

, ui anticholinergic effects, such as dry mouth, blurred vision, and constipation.
ui u i u i u i u i u i u i u i u i




KEY: Cognitive
ui u i Level: Application
ui u i | Integrated Processes: Nursing Process: Assessment | Client
ui u i u i u i ui u i ui


Need:
u i